inhaled beta-agonists MIGHT increase the risk of heart attacks in COPD patients

There's new concern that inhaled beta-agonists MIGHT increase the risk of heart attacks in COPD patients.

Many COPD patients get salbutamol or another inhaled beta-agonist to improve breathing.

But new evidence suggests a higher risk of unstable angina and heart attacks in patients using inhaled beta-agonists.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote